BioWorld

April 29, 2008

Targeted Genetics' Gene Therapy Shown to Improve Vision

Data reported from two separate studies showed that gene therapy improved the vision of some patients with a rare inherited degenerative eye disease that leads to blindness by age 30. (BioWorld Today) Read More

Quaker Aiming to Invest $420M Fund in Mid-Atlantic Companies

Allergy Kinase May Find Second Home in HIV Targeting Programs

Nuon Raises $27M to Move Tranilast Through Phase II

Other News To Note

Clinic Roundup

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Jan 30, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 30, 2026.

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

Centessa’s CNT-9982 shows promise for MDD

BioWorld Science

Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...

First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

BioWorld Science

Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...